Table 2.
Characteristics of the longitudinal SARS-CoV-2 cohorts vaccinated with a short or a long interval
| Short interval | Long interval | ||||
|---|---|---|---|---|---|
| SARS-CoV-2 naive | SARS-CoV-2 previously infected | SARS-CoV-2 naive | SARS-CoV-2 previously infected | ||
| Number | 45 | 16 | 30 | 15 | |
| Age | 35 (22–67) | 35 (23–59) | 51 (21–64) | 47 (29–65) | |
| Gender | male (n) | 21 | 10 | 12 | 10 |
| female (n) | 24 | 6 | 18 | 5 | |
| Days between symptom onset and the first dosea | N/A | 102 (50–275) | N/A | 274 (166–321) | |
| Days between the first and second dosesa | 21 (21–35) | 21 (21–30) | 111 (76–120) | 110 (90–134) | |
| Days between the second and third dosesa | 258 (183–342) | 276 (244–308) | 219 (167–230) | 219 (187–235) | |
a
Values displayed are medians, with ranges in parentheses.